Doha: The Ministry of Public Health has approved the use of a fourth vaccine dose of Pfizer/BioNTech and Moderna COVID-19 vaccines for individuals at high-risk of severe infection.
The fourth dose is only applicable to individuals 60 years of age and older and those with chronic diseases that increase their risk for severe COVID-19 infection, regardless of their age. The fourth dose will be offered to these individuals after four months from…